EHF anticorps (C-Term)
Aperçu rapide pour EHF anticorps (C-Term) (ABIN6952395)
Antigène
Voir toutes EHF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Polyclonal antibody raised in rabbit against human EHF (ETS Homologous Factor), using two synthetic peptides containing a sequence from the central part and the C-terminus of the protein, respectively.
-
Purification
- Peptide affinity purified
-
Immunogène
- synthetic peptide
-
-
-
-
Indications d'application
-
ChIP/ChIP-seq 1 - 2 μg:ChIP
ELISA 1:1,000 - 1:50,000
WB not recommended -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.1 μg/μL
-
Buffer
- PBS, 0.05 % azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- EHF (Ets Homologous Factor (EHF))
-
Autre désignation
- EHF
-
Sujet
- EHF (UniProtKB/Swiss-Prot entry Q9NZC4) belongs to the ETS transcription factor family. This transcriptional activator shows epithelial-specific expression and plays a role in regulating epithelial cell differentiation and proliferation. EHF may also act as a transcriptional repressor of a specific subset of ETS/AP-1-responsive genes and as a modulator of the nuclear response to mitogen-activated protein kinase signaling cascades. EHF is also a putative tumor suppressor gene and may be involved in carcinogenesis.
-
UniProt
- Q9NZC4
Antigène
-